Page last updated: 2024-11-02

pilsicainide and Cardiac Complex, Premature

pilsicainide has been researched along with Cardiac Complex, Premature in 2 studies

pilsicainide: structure given in first source
pilsicainide : A secondary carboxamide resulting from the formal condensation of the amino group of 2,6-dimethylaniline with the carboxy group of (tetrahydro-1H-pyrrolizin-7a(5H)-yl)acetic acid. It is a sodium channel blocker which is used as an antiarrhythmic drug for the management of atrial tachyarrhythmias in Japan.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nakazato, Y1
Nakata, Y1
Yasuda, M1
Yamagami, S1
Tokano, T1
Nakazato, K1
Sumiyoshi, M1
Ogura, S1
Yamaguchi, H1
Hattori, Y1
Hidaka, T1
Aisaka, K1
Satoh, F1
Ishihara, T1

Other Studies

2 other studies available for pilsicainide and Cardiac Complex, Premature

ArticleYear
Idiopathic ventricular fibrillation initiated by a short-coupled ventricular premature beat.
    Japanese heart journal, 1996, Volume: 37, Issue:2

    Topics: Adult; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Drug Therapy, Combination; Electrocardi

1996
Effect of SUN 1165, a new potent antiarrhythmic agent, on the kinetics of rate-dependent block of Na channels and ventricular conduction of extrasystoles.
    Journal of cardiovascular pharmacology, 1988, Volume: 11, Issue:4

    Topics: Animals; Anti-Arrhythmia Agents; Benzeneacetamides; Cardiac Complexes, Premature; Disopyramide; Guin

1988